Sort
23,748 grants matching “melanoma”
Cellular Mechanisms Controlling Myc Protein Stability
$306,921Rosalie C Sears · Oregon Health & Science University · R01 · FY2007 · CA
Improving early detection of melanoma with skin self examination
$306,705Myles G Cockburn · University Of Southern California · R01 · FY2008 · CA
The GNAQ pathway as a therapeutic target in uveal melanoma
$306,698Boris C Bastian · University Of California, San Francisco · R01 · FY2016 · CA
The GNAQ pathway as a therapeutic target in uveal melanoma
$306,698Boris C Bastian · University Of California, San Francisco · R01 · FY2017 · CA
Function of calcium exchangers in vetebrate pigmentation
$306,693Keith Chi Cheng · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · AR
Function of calcium exchangers in vetebrate pigmentation
$306,693Keith Chi Cheng · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2008 · AR
Core C: Cell Biology Core
$306,670Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
Project 3: Circumventing extracellular Adenosine barrier to oncolytic virotherapy
$306,607Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2023 · CA
Animal Models
$306,588Bernard E. Weissman · Univ Of North Carolina Chapel Hill · P30 · FY2017 · CA
Core 2: Animal and Pharmacology
$306,530Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2018 · CA
Targeting MFG-E8 as Melanoma Immunotherapy
$306,522Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Context-specific Functions of CDK8
$306,430Jun-Yuan Ji · Texas A&M University Health Science Ctr · R01 · FY2014 · DK
Context-specific Functions of CDK8
$306,430Jun-Yuan Ji · Texas A&M University Health Science Ctr · R01 · FY2016 · DK
Context-specific Functions of CDK8
$306,430Jun-Yuan Ji · Texas A&M University Health Science Ctr · R01 · FY2017 · DK
Context-specific Functions of CDK8
$306,430Jun-Yuan Ji · Texas A&M University Health Science Ctr · R01 · FY2015 · DK
HEF1 Coordination of Cell Cycle, Migration, and Invasion in Cancer
$306,415Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · CA
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol
$306,411Ying Huang · Western University Of Health Sciences · R01 · FY2024 · CA
Immunotherapy with Dendritic-Allogeneic Tumor Cells
$306,280Suyu Shu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Preclinical development of VAX024 - a novel targeted combination STING agonist/oncolytic agent
$306,265Matthew Giacalone · Vaxiion Therapeutics, Inc. · R43 · FY2025 · CA
Mechanistic Studies on New Platinum Clinical Agents
$306,250Virginia Commonwealth University · R01 · FY2003 · CA
Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.
$306,229Arnold I. Caplan · Case Western Reserve University · R01 · FY2013 · CA
Validation of Grm1 as a Therapeutic Target in Melanoma
$306,128James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2007 · CA
Intravital Microscopy Core
$306,070Roberto Weigert · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
PTEN Nuclear-Cytoplasmic Localization in Breast Cancer
$306,067Charis Eng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
Maximizing Memory T Cell Responses by Matured Post Chemotherapy Dendritic Cells
$306,063Mark P Rubinstein · Medical University Of South Carolina · R01 · FY2010 · CA